Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Octreotide.

Gregory V Stajich1, Laurel Ashworth

  • 1Mercer University College of Pharmacy and Health Sciences, Atlanta, Georgia, USA.

Neonatal Network : NN
|September 23, 2006
PubMed
Summary
This summary is machine-generated.

Octreotide therapy offers a promising treatment for reducing chyle drainage in patients with congenital or postoperative chylothorax unresponsive to conservative methods. Individualized treatment is crucial due to variable patient responses and limited pediatric data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination pharmacotherapy in the treatment of pulmonary arterial hypertension: continuing education article.

Journal of pharmacy practice·2013
Same author

An active-learning assignment using nonprescription medicines.

American journal of pharmaceutical education·2008
Same journal

A Quality Improvement Project to Increase Breastfeeding Rates in the NICU.

Neonatal network : NN·2026
Same journal

Parental Advocacy in the NICU: A Unique Case of Infant Hypoglycemia Highlighting the Role of the Family in Improving Outcomes.

Neonatal network : NN·2026
Same journal

Enteral Iron Supplementation.

Neonatal network : NN·2026
Same journal

Enjoyment in Preterm Infants: Exploring Clinical and Research Perspectives in the Neonatal Intensive Care Unit.

Neonatal network : NN·2026
Same journal

Building the Future Neonatal Nurse Practitioner Workforce: Reviewing Barriers and Strategies to Enrollment.

Neonatal network : NN·2026
Same journal

What Does It Mean to Be a Professional?

Neonatal network : NN·2026
See all related articles

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Surgical Complications

Background:

  • Chylothorax, a rare condition involving lymphatic fluid in the chest cavity, can be congenital or postoperative.
  • Conservative treatments for chylothorax are often ineffective in selected patient groups.
  • Prolonged hospital stays associated with chylothorax increase morbidity and healthcare costs.

Purpose of the Study:

  • To evaluate octreotide as a pharmacologic intervention for reducing chyle drainage in patients with refractory chylothorax.
  • To explore the potential benefits of early octreotide administration in managing postoperative chylothorax.

Main Methods:

  • Administration of octreotide (subcutaneous or intravenous) to patients with congenital or postoperative chylothorax.
  • Monitoring of chyle drainage and patient response to octreotide therapy.

Related Experiment Videos

  • Review of existing clinical data, particularly in the pediatric population.

    • Main Results:

    • Octreotide demonstrates potential in reducing chyle drainage in specific patient populations.
    • Early initiation of octreotide therapy may mitigate prolonged hospital stays and associated complications.
    • Significant individual variability in patient response to octreotide was observed.

    Conclusions:

    • Octreotide represents a viable pharmacologic option for managing refractory chylothorax.
    • Individualized octreotide therapy, balancing benefits and risks, is recommended.
    • Further research is needed to optimize octreotide use in pediatric chylothorax cases.